Category Archives: Strategy

Gain Competitive Advantage: Think Like a Navy SEAL

Pharmaceutical professionals, teams, and organizations can succeed at an elite level by tackling the tough mental challenges of Navy SEAL training, writes Stan Bernard. Victorious warriors win first in their minds, and then go to war. Defeated warriors go to war first and then seek to win. — Sun Tzu, Author of The Art of War (544 BCE-496 BCE) […]
Also posted in Guest Blog, Marketing, Op-Ed | Tagged , , | 1 Comment

ADHD Market to Reach Nearly $10 Billion by 2020

The Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market value will rise from $6.9 billion in 2013 to $9.9 billion by 2020, with broadening diagnostic criteria a key driver of growth, according to GBI Research. The company’s new report states that the increase — which represents a Compound Annual Growth Rate (CAGR) of 5.3% and relates to […]
Also posted in Global | Tagged , , , | Leave a comment

M&As: Past, Present, and Future

Pharmaceutical Technology’s Faiz Kermani looks at the long history of pharma mergers and finds no sign of the trend slowing down. It was suggested that in one week of April the total value of various rumored deals was of the order of US$100 billion, illustrating how cash-rich major pharmaceutical companies are. Many of the larger […]
Also posted in Deals, Emerging Markets, Europe, Global, Guest Blog, R&D | Tagged , , | Leave a comment

Brown University’s Executive Masters in Healthcare Leadership: A Mission to Transform

Mid-career students at Brown University’s new Executive Masters in Healthcare Leadership program are challenging the status quo with workplace projects focused on one thing: removing the organizational silos that slow innovations in the delivery and financing of healthcare. As the US healthcare system stumbles toward a new consensus built around the “triple aim” of increased […]
Posted in Strategy | Tagged , , | Leave a comment

Emerging Pharma Leader: Joerg Ahlgrimm, Baxter BioScience

By the middle of 2015, global healthcare giant Baxter International Inc. is expected to officially split off its BioScience business, establishing the unit as an independent, innovation-focused biotechnology company. Helming the operational component of these pursuits will be Joerg Ahlgrimm, 41, the division’s current vice president of operations and global supply chain. Ahlgrimm was appointed […]
Also posted in leadership | Tagged , , | Leave a comment
  • Categories

  • Meta